1 Market Overview 1.1 Product Overview and Scope of Gene Therapy in Oncology 1.2 Classification of Gene Therapy in Oncology by Type 1.2.1 Overview: Global Gene Therapy in Oncology Market Size by Type: 2020 Versus 2021 Versus 2026 1.2.2 Global Gene Therapy in Oncology Revenue Market Share by Type in 2020 1.2.3 Ex Vivo 1.2.4 In Vivo 1.3 Global Gene Therapy in Oncology Market by Application 1.3.1 Overview: Global Gene Therapy in Oncology Market Size by Application: 2020 Versus 2021 Versus 2026 1.3.2 Hospitals 1.3.3 Diagnostics Centers 1.3.4 Research Institutes 1.4 Global Gene Therapy in Oncology Market Size & Forecast 1.5 Global Gene Therapy in Oncology Market Size and Forecast by Region 1.5.1 Global Gene Therapy in Oncology Market Size by Region: 2016 VS 2021 VS 2026 1.5.2 Global Gene Therapy in Oncology Market Size by Region, (2016-2021) 1.5.3 North America Gene Therapy in Oncology Market Size and Prospect (2016-2026) 1.5.4 Europe Gene Therapy in Oncology Market Size and Prospect (2016-2026) 1.5.5 Asia-Pacific Gene Therapy in Oncology Market Size and Prospect (2016-2026) 1.5.6 South America Gene Therapy in Oncology Market Size and Prospect (2016-2026) 1.5.7 Middle East and Africa Gene Therapy in Oncology Market Size and Prospect (2016-2026) 1.6 Market Drivers, Restraints and Trends 1.6.1 Gene Therapy in Oncology Market Drivers 1.6.2 Gene Therapy in Oncology Market Restraints 1.6.3 Gene Therapy in Oncology Trends Analysis 2 Company Profiles 2.1 Bristol-Myers Squibb 2.1.1 Bristol-Myers Squibb Details 2.1.2 Bristol-Myers Squibb Major Business 2.1.3 Bristol-Myers Squibb Gene Therapy in Oncology Product and Solutions 2.1.4 Bristol-Myers Squibb Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2019-2021) 2.1.5 Bristol-Myers Squibb Recent Developments and Future Plans 2.2 Cold Genesys 2.2.1 Cold Genesys Details 2.2.2 Cold Genesys Major Business 2.2.3 Cold Genesys Gene Therapy in Oncology Product and Solutions 2.2.4 Cold Genesys Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2019-2021) 2.2.5 Cold Genesys Recent Developments and Future Plans 2.3 Advantagene 2.3.1 Advantagene Details 2.3.2 Advantagene Major Business 2.3.3 Advantagene Gene Therapy in Oncology Product and Solutions 2.3.4 Advantagene Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2019-2021) 2.3.5 Advantagene Recent Developments and Future Plans 2.4 Amgen 2.4.1 Amgen Details 2.4.2 Amgen Major Business 2.4.3 Amgen Gene Therapy in Oncology Product and Solutions 2.4.4 Amgen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2019-2021) 2.4.5 Amgen Recent Developments and Future Plans 2.5 AstraZeneca 2.5.1 AstraZeneca Details 2.5.2 AstraZeneca Major Business 2.5.3 AstraZeneca Gene Therapy in Oncology Product and Solutions 2.5.4 AstraZeneca Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2019-2021) 2.5.5 AstraZeneca Recent Developments and Future Plans 2.6 Bio-Path Holdings 2.6.1 Bio-Path Holdings Details 2.6.2 Bio-Path Holdings Major Business 2.6.3 Bio-Path Holdings Gene Therapy in Oncology Product and Solutions 2.6.4 Bio-Path Holdings Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2019-2021) 2.6.5 Bio-Path Holdings Recent Developments and Future Plans 2.7 CRISPR Therapeutics 2.7.1 CRISPR Therapeutics Details 2.7.2 CRISPR Therapeutics Major Business 2.7.3 CRISPR Therapeutics Gene Therapy in Oncology Product and Solutions 2.7.4 CRISPR Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2019-2021) 2.7.5 CRISPR Therapeutics Recent Developments and Future Plans 2.8 Editas Medicine 2.8.1 Editas Medicine Details 2.8.2 Editas Medicine Major Business 2.8.3 Editas Medicine Gene Therapy in Oncology Product and Solutions 2.8.4 Editas Medicine Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2019-2021) 2.8.5 Editas Medicine Recent Developments and Future Plans 2.9 Geron Corp 2.9.1 Geron Corp Details 2.9.2 Geron Corp Major Business 2.9.3 Geron Corp Gene Therapy in Oncology Product and Solutions 2.9.4 Geron Corp Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2019-2021) 2.9.5 Geron Corp Recent Developments and Future Plans 2.10 Idera Pharmaceuticals 2.10.1 Idera Pharmaceuticals Details 2.10.2 Idera Pharmaceuticals Major Business 2.10.3 Idera Pharmaceuticals Gene Therapy in Oncology Product and Solutions 2.10.4 Idera Pharmaceuticals Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2019-2021) 2.10.5 Idera Pharmaceuticals Recent Developments and Future Plans 2.11 Intellia Therapeutics 2.11.1 Intellia Therapeutics Details 2.11.2 Intellia Therapeutics Major Business 2.11.3 Intellia Therapeutics Gene Therapy in Oncology Product and Solutions 2.11.4 Intellia Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2019-2021) 2.11.5 Intellia Therapeutics Recent Developments and Future Plans 2.12 Johnson & Johnson 2.12.1 Johnson & Johnson Details 2.12.2 Johnson & Johnson Major Business 2.12.3 Johnson & Johnson Gene Therapy in Oncology Product and Solutions 2.12.4 Johnson & Johnson Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2019-2021) 2.12.5 Johnson & Johnson Recent Developments and Future Plans 2.13 Marsala Biotech 2.13.1 Marsala Biotech Details 2.13.2 Marsala Biotech Major Business 2.13.3 Marsala Biotech Gene Therapy in Oncology Product and Solutions 2.13.4 Marsala Biotech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2019-2021) 2.13.5 Marsala Biotech Recent Developments and Future Plans 2.14 Merck 2.14.1 Merck Details 2.14.2 Merck Major Business 2.14.3 Merck Gene Therapy in Oncology Product and Solutions 2.14.4 Merck Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2019-2021) 2.14.5 Merck Recent Developments and Future Plans 2.15 Mologen AG 2.15.1 Mologen AG Details 2.15.2 Mologen AG Major Business 2.15.3 Mologen AG Gene Therapy in Oncology Product and Solutions 2.15.4 Mologen AG Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2019-2021) 2.15.5 Mologen AG Recent Developments and Future Plans 2.16 Oncolytics Biotech 2.16.1 Oncolytics Biotech Details 2.16.2 Oncolytics Biotech Major Business 2.16.3 Oncolytics Biotech Gene Therapy in Oncology Product and Solutions 2.16.4 Oncolytics Biotech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2019-2021) 2.16.5 Oncolytics Biotech Recent Developments and Future Plans 2.17 Oncosec 2.17.1 Oncosec Details 2.17.2 Oncosec Major Business 2.17.3 Oncosec Gene Therapy in Oncology Product and Solutions 2.17.4 Oncosec Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2019-2021) 2.17.5 Oncosec Recent Developments and Future Plans 2.18 Oncotelic 2.18.1 Oncotelic Details 2.18.2 Oncotelic Major Business 2.18.3 Oncotelic Gene Therapy in Oncology Product and Solutions 2.18.4 Oncotelic Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2019-2021) 2.18.5 Oncotelic Recent Developments and Future Plans 2.19 Shenzhen SiBiono GeneTech 2.19.1 Shenzhen SiBiono GeneTech Details 2.19.2 Shenzhen SiBiono GeneTech Major Business 2.19.3 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product and Solutions 2.19.4 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2019-2021) 2.19.5 Shenzhen SiBiono GeneTech Recent Developments and Future Plans 2.20 Sillajen Biotherapeutics 2.20.1 Sillajen Biotherapeutics Details 2.20.2 Sillajen Biotherapeutics Major Business 2.20.3 Sillajen Biotherapeutics Gene Therapy in Oncology Product and Solutions 2.20.4 Sillajen Biotherapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2019-2021) 2.20.5 Sillajen Biotherapeutics Recent Developments and Future Plans 2.21 Tocagen 2.21.1 Tocagen Details 2.21.2 Tocagen Major Business 2.21.3 Tocagen Gene Therapy in Oncology Product and Solutions 2.21.4 Tocagen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2019-2021) 2.21.5 Tocagen Recent Developments and Future Plans 2.22 UniQure 2.22.1 UniQure Details 2.22.2 UniQure Major Business 2.22.3 UniQure Gene Therapy in Oncology Product and Solutions 2.22.4 UniQure Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2019-2021) 2.22.5 UniQure Recent Developments and Future Plans 2.23 Ziopharm Oncology 2.23.1 Ziopharm Oncology Details 2.23.2 Ziopharm Oncology Major Business 2.23.3 Ziopharm Oncology Gene Therapy in Oncology Product and Solutions 2.23.4 Ziopharm Oncology Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2019-2021) 2.23.5 Ziopharm Oncology Recent Developments and Future Plans 3 Market Competition, by Players 3.1 Global Gene Therapy in Oncology Revenue and Share by Players (2019-2021) 3.2 Market Concentration Rate 3.2.1 Top 3 Gene Therapy in Oncology Players Market Share 3.2.2 Top 10 Gene Therapy in Oncology Players Market Share 3.2.3 Market Competition Trend 3.3 Gene Therapy in Oncology Players Head Office, Products and Services Provided 3.4 Mergers & Acquisitions 3.5 New Entrants and Expansion Plans 4 Market Size Segment by Type 4.1 Global Gene Therapy in Oncology Revenue and Market Share by Type (2016-2021) 4.2 Global Gene Therapy in Oncology Market Forecast by Type (2021-2026) 5 Market Size Segment by Application 5.1 Global Gene Therapy in Oncology Revenue Market Share by Application (2016-2021) 5.2 Gene Therapy in Oncology Market Forecast by Application (2021-2026) 6 North America by Country, by Type, and by Application 6.1 North America Gene Therapy in Oncology Revenue by Type (2016-2026) 6.2 North America Gene Therapy in Oncology Revenue by Application (2016-2026) 6.3 North America Gene Therapy in Oncology Market Size by Country 6.3.1 North America Gene Therapy in Oncology Revenue by Country (2016-2026) 6.3.2 United States Gene Therapy in Oncology Market Size and Forecast (2016-2026) 6.3.3 Canada Gene Therapy in Oncology Market Size and Forecast (2016-2026) 6.3.4 Mexico Gene Therapy in Oncology Market Size and Forecast (2016-2026) 7 Europe by Country, by Type, and by Application 7.1 Europe Gene Therapy in Oncology Revenue by Type (2016-2026) 7.2 Europe Gene Therapy in Oncology Revenue by Application (2016-2026) 7.3 Europe Gene Therapy in Oncology Market Size by Country 7.3.1 Europe Gene Therapy in Oncology Revenue by Country (2016-2026) 7.3.2 Germany Gene Therapy in Oncology Market Size and Forecast (2016-2026) 7.3.3 France Gene Therapy in Oncology Market Size and Forecast (2016-2026) 7.3.4 United Kingdom Gene Therapy in Oncology Market Size and Forecast (2016-2026) 7.3.5 Russia Gene Therapy in Oncology Market Size and Forecast (2016-2026) 7.3.6 Italy Gene Therapy in Oncology Market Size and Forecast (2016-2026) 8 Asia-Pacific by Region, by Type, and by Application 8.1 Asia-Pacific Gene Therapy in Oncology Revenue by Type (2016-2026) 8.2 Asia-Pacific Gene Therapy in Oncology Revenue by Application (2016-2026) 8.3 Asia-Pacific Gene Therapy in Oncology Market Size by Region 8.3.1 Asia-Pacific Gene Therapy in Oncology Revenue by Region (2016-2026) 8.3.2 China Gene Therapy in Oncology Market Size and Forecast (2016-2026) 8.3.3 Japan Gene Therapy in Oncology Market Size and Forecast (2016-2026) 8.3.4 South Korea Gene Therapy in Oncology Market Size and Forecast (2016-2026) 8.3.5 India Gene Therapy in Oncology Market Size and Forecast (2016-2026) 8.3.6 Southeast Asia Gene Therapy in Oncology Market Size and Forecast (2016-2026) 8.3.7 Australia Gene Therapy in Oncology Market Size and Forecast (2016-2026) 9 South America by Country, by Type, and by Application 9.1 South America Gene Therapy in Oncology Revenue by Type (2016-2026) 9.2 South America Gene Therapy in Oncology Revenue by Application (2016-2026) 9.3 South America Gene Therapy in Oncology Market Size by Country 9.3.1 South America Gene Therapy in Oncology Revenue by Country (2016-2026) 9.3.2 Brazil Gene Therapy in Oncology Market Size and Forecast (2016-2026) 9.3.3 Argentina Gene Therapy in Oncology Market Size and Forecast (2016-2026) 10 Middle East & Africa by Country, by Type, and by Application 10.1 Middle East & Africa Gene Therapy in Oncology Revenue by Type (2016-2026) 10.2 Middle East & Africa Gene Therapy in Oncology Revenue by Application (2016-2026) 10.3 Middle East & Africa Gene Therapy in Oncology Market Size by Country 10.3.1 Middle East & Africa Gene Therapy in Oncology Revenue by Country (2016-2026) 10.3.2 Turkey Gene Therapy in Oncology Market Size and Forecast (2016-2026) 10.3.3 Saudi Arabia Gene Therapy in Oncology Market Size and Forecast (2016-2026) 10.3.4 UAE Gene Therapy in Oncology Market Size and Forecast (2016-2026) 11 Research Findings and Conclusion 12 Appendix 12.1 Methodology 12.2 Research Process and Data Source 12.3 Disclaimer

List of Tables Table 1. Global Gene Therapy in Oncology Revenue by Type, (USD Million), 2020 VS 2021 VS 2026 Table 2. Global Gene Therapy in Oncology Revenue by Application, (USD Million), 2020 VS 2021 VS 2026 Table 3. Global Market Gene Therapy in Oncology Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026) Table 4. Global Gene Therapy in Oncology Revenue (USD Million) by Region (2016-2021) Table 5. Global Gene Therapy in Oncology Revenue Market Share by Region (2021-2026) Table 6. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors Table 7. Bristol-Myers Squibb Major Business Table 8. Bristol-Myers Squibb Gene Therapy in Oncology Product and Solutions Table 9. Bristol-Myers Squibb Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 10. Cold Genesys Corporate Information, Head Office, and Major Competitors Table 11. Cold Genesys Major Business Table 12. Cold Genesys Gene Therapy in Oncology Product and Solutions Table 13. Cold Genesys Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 14. Advantagene Corporate Information, Head Office, and Major Competitors Table 15. Advantagene Major Business Table 16. Advantagene Gene Therapy in Oncology Product and Solutions Table 17. Advantagene Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 18. Amgen Corporate Information, Head Office, and Major Competitors Table 19. Amgen Major Business Table 20. Amgen Gene Therapy in Oncology Product and Solutions Table 21. Amgen Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 22. AstraZeneca Corporate Information, Head Office, and Major Competitors Table 23. AstraZeneca Major Business Table 24. AstraZeneca Gene Therapy in Oncology Product and Solutions Table 25. AstraZeneca Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 26. Bio-Path Holdings Corporate Information, Head Office, and Major Competitors Table 27. Bio-Path Holdings Major Business Table 28. Bio-Path Holdings Gene Therapy in Oncology Product and Solutions Table 29. Bio-Path Holdings Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 30. CRISPR Therapeutics Corporate Information, Head Office, and Major Competitors Table 31. CRISPR Therapeutics Major Business Table 32. CRISPR Therapeutics Gene Therapy in Oncology Product and Solutions Table 33. CRISPR Therapeutics Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 34. Editas Medicine Corporate Information, Head Office, and Major Competitors Table 35. Editas Medicine Major Business Table 36. Editas Medicine Gene Therapy in Oncology Product and Solutions Table 37. Editas Medicine Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 38. Geron Corp Corporate Information, Head Office, and Major Competitors Table 39. Geron Corp Major Business Table 40. Geron Corp Gene Therapy in Oncology Product and Solutions Table 41. Geron Corp Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 42. Idera Pharmaceuticals Corporate Information, Head Office, and Major Competitors Table 43. Idera Pharmaceuticals Major Business Table 44. Idera Pharmaceuticals Gene Therapy in Oncology Product and Solutions Table 45. Idera Pharmaceuticals Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 46. Intellia Therapeutics Corporate Information, Head Office, and Major Competitors Table 47. Intellia Therapeutics Major Business Table 48. Intellia Therapeutics Gene Therapy in Oncology Product and Solutions Table 49. Intellia Therapeutics Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 50. Johnson & Johnson Corporate Information, Head Office, and Major Competitors Table 51. Johnson & Johnson Major Business Table 52. Johnson & Johnson Gene Therapy in Oncology Product and Solutions Table 53. Johnson & Johnson Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 54. Marsala Biotech Corporate Information, Head Office, and Major Competitors Table 55. Marsala Biotech Major Business Table 56. Marsala Biotech Gene Therapy in Oncology Product and Solutions Table 57. Marsala Biotech Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 58. Merck Corporate Information, Head Office, and Major Competitors Table 59. Merck Major Business Table 60. Merck Gene Therapy in Oncology Product and Solutions Table 61. Merck Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 62. Mologen AG Corporate Information, Head Office, and Major Competitors Table 63. Mologen AG Major Business Table 64. Mologen AG Gene Therapy in Oncology Product and Solutions Table 65. Mologen AG Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 66. Oncolytics Biotech Corporate Information, Head Office, and Major Competitors Table 67. Oncolytics Biotech Major Business Table 68. Oncolytics Biotech Gene Therapy in Oncology Product and Solutions Table 69. Oncolytics Biotech Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 70. Oncosec Corporate Information, Head Office, and Major Competitors Table 71. Oncosec Major Business Table 72. Oncosec Gene Therapy in Oncology Product and Solutions Table 73. Oncosec Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 74. Oncotelic Corporate Information, Head Office, and Major Competitors Table 75. Oncotelic Major Business Table 76. Oncotelic Gene Therapy in Oncology Product and Solutions Table 77. Oncotelic Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 78. Shenzhen SiBiono GeneTech Corporate Information, Head Office, and Major Competitors Table 79. Shenzhen SiBiono GeneTech Major Business Table 80. Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product and Solutions Table 81. Shenzhen SiBiono GeneTech Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 82. Sillajen Biotherapeutics Corporate Information, Head Office, and Major Competitors Table 83. Sillajen Biotherapeutics Major Business Table 84. Sillajen Biotherapeutics Gene Therapy in Oncology Product and Solutions Table 85. Sillajen Biotherapeutics Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 86. Tocagen Corporate Information, Head Office, and Major Competitors Table 87. Tocagen Major Business Table 88. Tocagen Gene Therapy in Oncology Product and Solutions Table 89. Tocagen Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 90. UniQure Corporate Information, Head Office, and Major Competitors Table 91. UniQure Major Business Table 92. UniQure Gene Therapy in Oncology Product and Solutions Table 93. UniQure Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 94. Ziopharm Oncology Corporate Information, Head Office, and Major Competitors Table 95. Ziopharm Oncology Major Business Table 96. Ziopharm Oncology Gene Therapy in Oncology Product and Solutions Table 97. Ziopharm Oncology Gene Therapy in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 98. Global Gene Therapy in Oncology Revenue (USD Million) by Players (2019-2021) Table 99. Global Gene Therapy in Oncology Revenue Share by Players (2019-2021) Table 100. Breakdown of Gene Therapy in Oncology by Company Type (Tier 1, Tier 2 and Tier 3) Table 101. Gene Therapy in Oncology Players Head Office, Products and Services Provided Table 102. Gene Therapy in Oncology Mergers & Acquisitions in the Past Five Years Table 103. Gene Therapy in Oncology New Entrants and Expansion Plans Table 104. Global Gene Therapy in Oncology Revenue (USD Million) by Type (2016-2021) Table 105. Global Gene Therapy in Oncology Revenue Share by Type (2016-2021) Table 106. Global Gene Therapy in Oncology Revenue Forecast by Type (2021-2026) Table 107. Global Gene Therapy in Oncology Revenue by Application (2016-2021) Table 108. Global Gene Therapy in Oncology Revenue Forecast by Application (2021-2026) Table 109. North America Gene Therapy in Oncology Revenue by Type (2016-2021) & (USD Million) Table 110. North America Gene Therapy in Oncology Revenue by Type (2021-2026) & (USD Million) Table 111. North America Gene Therapy in Oncology Revenue by Application (2016-2021) & (USD Million) Table 112. North America Gene Therapy in Oncology Revenue by Application (2021-2026) & (USD Million) Table 113. North America Gene Therapy in Oncology Revenue by Country (2016-2021) & (USD Million) Table 114. North America Gene Therapy in Oncology Revenue by Country (2021-2026) & (USD Million) Table 115. Europe Gene Therapy in Oncology Revenue by Type (2016-2021) & (USD Million) Table 116. Europe Gene Therapy in Oncology Revenue by Type (2021-2026) & (USD Million) Table 117. Europe Gene Therapy in Oncology Revenue by Application (2016-2021) & (USD Million) Table 118. Europe Gene Therapy in Oncology Revenue by Application (2021-2026) & (USD Million) Table 119. Europe Gene Therapy in Oncology Revenue by Country (2016-2021) & (USD Million) Table 120. Europe Gene Therapy in Oncology Revenue by Country (2021-2026) & (USD Million) Table 121. Asia-Pacific Gene Therapy in Oncology Revenue by Type (2016-2021) & (USD Million) Table 122. Asia-Pacific Gene Therapy in Oncology Revenue by Type (2021-2026) & (USD Million) Table 123. Asia-Pacific Gene Therapy in Oncology Revenue by Application (2016-2021) & (USD Million) Table 124. Asia-Pacific Gene Therapy in Oncology Revenue by Application (2021-2026) & (USD Million) Table 125. Asia-Pacific Gene Therapy in Oncology Revenue by Region (2016-2021) & (USD Million) Table 126. Asia-Pacific Gene Therapy in Oncology Revenue by Region (2021-2026) & (USD Million) Table 127. South America Gene Therapy in Oncology Revenue by Type (2016-2021) & (USD Million) Table 128. South America Gene Therapy in Oncology Revenue by Type (2021-2026) & (USD Million) Table 129. South America Gene Therapy in Oncology Revenue by Application (2016-2021) & (USD Million) Table 130. South America Gene Therapy in Oncology Revenue by Application (2021-2026) & (USD Million) Table 131. South America Gene Therapy in Oncology Revenue by Country (2016-2021) & (USD Million) Table 132. South America Gene Therapy in Oncology Revenue by Country (2021-2026) & (USD Million) Table 133. Middle East & Africa Gene Therapy in Oncology Revenue by Type (2016-2021) & (USD Million) Table 134. Middle East & Africa Gene Therapy in Oncology Revenue by Type (2021-2026) & (USD Million) Table 135. Middle East & Africa Gene Therapy in Oncology Revenue by Application (2016-2021) & (USD Million) Table 136. Middle East & Africa Gene Therapy in Oncology Revenue by Application (2021-2026) & (USD Million) Table 137. Middle East & Africa Gene Therapy in Oncology Revenue by Country (2016-2021) & (USD Million) Table 138. Middle East & Africa Gene Therapy in Oncology Revenue by Country (2021-2026) & (USD Million) List of Figures Figure 1. Gene Therapy in Oncology Picture Figure 2. Global Gene Therapy in Oncology Revenue Market Share by Type in 2020 Figure 3. Ex Vivo Figure 4. In Vivo Figure 5. Gene Therapy in Oncology Revenue Market Share by Application in 2020 Figure 6. Hospitals Picture Figure 7. Diagnostics Centers Picture Figure 8. Research Institutes Picture Figure 9. Global Gene Therapy in Oncology Revenue, (USD Million): 2020 VS 2021 VS 2026 Figure 10. Global Gene Therapy in Oncology Revenue and Forecast (2016-2026) & (USD Million) Figure 11. Global Gene Therapy in Oncology Revenue Market Share by Region (2016-2026) Figure 12. Global Gene Therapy in Oncology Revenue Market Share by Region in 2020 Figure 13. North America Gene Therapy in Oncology Revenue (USD Million) and Growth Rate (2016-2026) Figure 14. Europe Gene Therapy in Oncology Revenue (USD Million) and Growth Rate (2016-2026) Figure 15. Asia-Pacific Gene Therapy in Oncology Revenue (USD Million) and Growth Rate (2016-2026) Figure 16. South America Gene Therapy in Oncology Revenue (USD Million) and Growth Rate (2016-2026) Figure 17. Middle East and Africa Gene Therapy in Oncology Revenue (USD Million) and Growth Rate (2016-2026) Figure 18. Gene Therapy in Oncology Market Drivers Figure 19. Gene Therapy in Oncology Market Restraints Figure 20. Gene Therapy in Oncology Market Trends Figure 21. Bristol-Myers Squibb Recent Developments and Future Plans Figure 22. Cold Genesys Recent Developments and Future Plans Figure 23. Advantagene Recent Developments and Future Plans Figure 24. Amgen Recent Developments and Future Plans Figure 25. AstraZeneca Recent Developments and Future Plans Figure 26. Bio-Path Holdings Recent Developments and Future Plans Figure 27. CRISPR Therapeutics Recent Developments and Future Plans Figure 28. Editas Medicine Recent Developments and Future Plans Figure 29. Geron Corp Recent Developments and Future Plans Figure 30. Idera Pharmaceuticals Recent Developments and Future Plans Figure 31. Intellia Therapeutics Recent Developments and Future Plans Figure 32. Johnson & Johnson Recent Developments and Future Plans Figure 33. Marsala Biotech Recent Developments and Future Plans Figure 34. Merck Recent Developments and Future Plans Figure 35. Mologen AG Recent Developments and Future Plans Figure 36. Oncolytics Biotech Recent Developments and Future Plans Figure 37. Oncosec Recent Developments and Future Plans Figure 38. Oncotelic Recent Developments and Future Plans Figure 39. Shenzhen SiBiono GeneTech Recent Developments and Future Plans Figure 40. Sillajen Biotherapeutics Recent Developments and Future Plans Figure 41. Tocagen Recent Developments and Future Plans Figure 42. UniQure Recent Developments and Future Plans Figure 43. Ziopharm Oncology Recent Developments and Future Plans Figure 44. Global Gene Therapy in Oncology Revenue Share by Players in 2020 Figure 45. Gene Therapy in Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure 46. Global Top 3 Players Gene Therapy in Oncology Revenue Market Share in 2020 Figure 47. Global Top 10 Players Gene Therapy in Oncology Revenue Market Share in 2020 Figure 48. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021) Figure 49. Global Gene Therapy in Oncology Revenue Share by Type in 2020 Figure 50. Global Gene Therapy in Oncology Market Share Forecast by Type (2021-2026) Figure 51. Global Gene Therapy in Oncology Revenue Share by Application in 2020 Figure 52. Global Gene Therapy in Oncology Market Share Forecast by Application (2021-2026) Figure 53. North America Gene Therapy in Oncology Sales Market Share by Type (2016-2026) Figure 54. North America Gene Therapy in Oncology Sales Market Share by Application (2016-2026) Figure 55. North America Gene Therapy in Oncology Revenue Market Share by Country (2016-2026) Figure 56. United States Gene Therapy in Oncology Revenue and Growth Rate (2016-2026) & (USD Million) Figure 57. Canada Gene Therapy in Oncology Revenue and Growth Rate (2016-2026) & (USD Million) Figure 58. Mexico Gene Therapy in Oncology Revenue and Growth Rate (2016-2026) & (USD Million) Figure 59. Europe Gene Therapy in Oncology Sales Market Share by Type (2016-2026) Figure 60. Europe Gene Therapy in Oncology Sales Market Share by Application (2016-2026) Figure 61. Europe Gene Therapy in Oncology Revenue Market Share by Country (2016-2026) Figure 62. Germany Gene Therapy in Oncology Revenue and Growth Rate (2016-2026) & (USD Million) Figure 63. France Gene Therapy in Oncology Revenue and Growth Rate (2016-2026) & (USD Million) Figure 64. United Kingdom Gene Therapy in Oncology Revenue and Growth Rate (2016-2026) & (USD Million) Figure 65. Russia Gene Therapy in Oncology Revenue and Growth Rate (2016-2026) & (USD Million) Figure 66. Italy Gene Therapy in Oncology Revenue and Growth Rate (2016-2026) & (USD Million) Figure 67. Asia-Pacific Gene Therapy in Oncology Sales Market Share by Type (2016-2026) Figure 68. Asia-Pacific Gene Therapy in Oncology Sales Market Share by Application (2016-2026) Figure 69. Asia-Pacific Gene Therapy in Oncology Revenue Market Share by Region (2016-2026) Figure 70. China Gene Therapy in Oncology Revenue and Growth Rate (2016-2026) & (USD Million) Figure 71. Japan Gene Therapy in Oncology Revenue and Growth Rate (2016-2026) & (USD Million) Figure 72. South Korea Gene Therapy in Oncology Revenue and Growth Rate (2016-2026) & (USD Million) Figure 73. India Gene Therapy in Oncology Revenue and Growth Rate (2016-2026) & (USD Million) Figure 74. Southeast Asia Gene Therapy in Oncology Revenue and Growth Rate (2016-2026) & (USD Million) Figure 75. Australia Gene Therapy in Oncology Revenue and Growth Rate (2016-2026) & (USD Million) Figure 76. South America Gene Therapy in Oncology Sales Market Share by Type (2016-2026) Figure 77. South America Gene Therapy in Oncology Sales Market Share by Application (2016-2026) Figure 78. South America Gene Therapy in Oncology Revenue Market Share by Country (2016-2026) Figure 79. Brazil Gene Therapy in Oncology Revenue and Growth Rate (2016-2026) & (USD Million) Figure 80. Argentina Gene Therapy in Oncology Revenue and Growth Rate (2016-2026) & (USD Million) Figure 81. Middle East and Africa Gene Therapy in Oncology Sales Market Share by Type (2016-2026) Figure 82. Middle East and Africa Gene Therapy in Oncology Sales Market Share by Application (2016-2026) Figure 83. Middle East and Africa Gene Therapy in Oncology Revenue Market Share by Country (2016-2026) Figure 84. Turkey Gene Therapy in Oncology Revenue and Growth Rate (2016-2026) & (USD Million) Figure 85. Saudi Arabia Gene Therapy in Oncology Revenue and Growth Rate (2016-2026) & (USD Million) Figure 86. UAE Gene Therapy in Oncology Revenue and Growth Rate (2016-2026) & (USD Million) Figure 87. Methodology Figure 88. Research Process and Data Source

Bristol-Myers Squibb Cold Genesys Advantagene Amgen AstraZeneca Bio-Path Holdings CRISPR Therapeutics Editas Medicine Geron Corp Idera Pharmaceuticals Intellia Therapeutics Johnson & Johnson Marsala Biotech Merck Mologen AG Oncolytics Biotech Oncosec Oncotelic Shenzhen SiBiono GeneTech Sillajen Biotherapeutics Tocagen UniQure Ziopharm Oncology